Melatonin Inhibition Effects describe the physiological consequences that result from the suppression of the nocturnal surge of the hormone melatonin, primarily due to inappropriate light exposure or certain pharmacological agents. Melatonin is a key chronobiotic hormone, and its inhibition disrupts the signaling of darkness to the central and peripheral clocks, leading to a state of internal desynchronization. These effects negatively impact sleep quality and metabolic regulation.
Origin
This term stems directly from the foundational research in chronobiology that established melatonin’s role as the “hormone of darkness,” secreted by the pineal gland. The discovery of how short-wavelength (blue) light acutely suppresses melatonin production provided the critical link between environmental light and internal hormonal signaling. It is a clinical description of a preventable endocrine disruption.
Mechanism
Light, particularly blue light, activates intrinsically photosensitive retinal ganglion cells (ipRGCs), which send signals via the retinohypothalamic tract to the suprachiasmatic nucleus (SCN), and subsequently inhibit the pineal gland’s production of N-acetyl-5-methoxytryptamine (melatonin). This suppression phase-shifts the circadian rhythm, delays sleep onset, and is associated with downstream metabolic dysregulation, including impaired glucose tolerance and reduced nocturnal repair processes.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.